Track Record

Senior team members at RM Global have advised on and completed the following transactions and assignments:

 

  • Geography
    • Americas
    • Asia
    • Europe & Israel
  • Sector
    • BioPharma
    • Medical Technology
    • Other (Dx, HC IT, etc.)
  • Service
    • Investment banking
    • Advisory
    • Consulting
Strategic investment and Distribution Agreement
Confidential
Advised Cosmotec
on the foregoing transaction
Equity investment in Elastagen’s Series B and Strategic Collaboration with Elastagen
Confidential
Advised AMOREPACIFIC
on the foregoing transaction
Series B Financing
$15 milion
Advised KAHR Medical
on the foregoing transaction
Series B Preferred Stock Financing
$7.5 milion
Advised Checkpoint Surgical
on the foregoing transaction
Equity Financing
$22.4 milion
Advised MediBeacon
on the foregoing transaction
Global Licensing Agreement Cardiovascular Device Platform
Confidential
Advised Distal Access
on the foregoing transaction
Series A Financing
Confidential
Advised Distal Access
on the foregoing transaction
Strategic Advisory Services
Confidential
Advised Riverain Technologies
on the foregoing transaction
Strategic Collaboration with Novartis to Screen & Develop Israel-Sourced Novel Drug Candidates
Confidential
Advised BioLineRx
on the foregoing transaction
Equity investment in Tria Beauty's series D and Strategic Collaboration with Tria Beauty
Confidential
Advised Amore Pacific
on the foregoing transaction
Equity investment in Brickell Bio's Series A and Strategic Collaboration with Brickell Bio
Confidential
Advised Amore Pacific
on the foregoing transaction
Equity investment in Neothetics (formerly "Lithera") Series C and Strategic Collaboration with Neothetics
Confidential
Advised Amore Pacific
on the foregoing transaction
Strategic consulting & execution
Confidential
Advised PacificPharma
on the foregoing transaction
Equity financing
Confidential
Advised U&I
on the foregoing transaction
Confidential
Advised Bioamber
on the foregoing transaction
Equity Financing
Confidential
Advised Alereon
on the foregoing transaction
Private Placement of Series B Financing Advice on business development & IPO
Confidential
Advised Oscotec
on the foregoing transaction
Sale of Pharmacuetical Business Assets to Handok
$55 million
Advised Amore Pacific
on the foregoing transaction
Strategic Advisory Services
Confidential
Advised Stentys
on the foregoing transaction
Strategic Advisory Services
Confidential
Advised Goodman Co. Ltd
on the foregoing transaction
Strategic Advisory Services
Confidential
Advised Cosmotec Co. Ltd.
on the foregoing transaction
Strategic Advisory Services
Confidential
Advised IASU Co.
on the foregoing transaction
Strategic Advisory Services
Confidential
Advised Marubeni
on the foregoing transaction
Screen & Identify new business opportunties
Confidential
Advised ILJIN Group
on the foregoing transaction
Acquisition
Confidential
Advised Kolon Group
on the foregoing transaction
Out-licensing various drug candidates to global bioPharma
Confidential
Advised LG Chemicals
on the foregoing transaction
Advising on investments and strategy in clean technology
Confidential
Advised Samsung Fine Chemicals
on the foregoing transaction
Strategic Advisory Services
Confidential
Advised Integra LifeSciences
on the foregoing transaction
Consulting
Confidential
Advised Pfizer
on the foregoing transaction
Private Placement
Confidential
Advised Expanding Orthopedics
on the foregoing transaction
Series D Private Equity Placement
$20 Million equity
Advised Obalon
on the foregoing transaction
Formation of AmorePacific Ventures
$70 million
Advised Amore Pacific
on the foregoing transaction
Private Placement (both series C and series D)
$41.6 Million
Advised Neothetics
on the foregoing transaction
Global partnership with Micell
Confidential
Advised Stentys
on the foregoing transaction
Acquisition of Cappella Delivery System
Confidential
Advised Stentys
on the foregoing transaction
Series D Financing
$21 million
Advised Micrus
on the foregoing transaction
Acquisition of LightLab
Confidential
Advised Goodman
on the foregoing transaction
Acquisition of Avantec Vascular
$160 million
Advised Goodman
on the foregoing transaction
Pinyons Medical Technology Has Been Acquired by Covidien
Confidential
Advised Pinyons Medical Technology
on the foregoing transaction
Acquisition and Financing of Spinout of Magellan Product Line & Related Assets from Medtronic
$10 million (growth financing)
Advised Arteriocyte Medical System
on the foregoing transaction
Spin-off and Financing
$8 million
Advised MiCardia
on the foregoing transaction
Equity Financing
$11 million
Advised Anterios
on the foregoing transaction
Series A Financing and Strategic Distribution Agreements
Confidential
Advised Control Medical Technology
on the foregoing transaction
Equity Investment in Obalon's Series C-1 and Strategic Collaboration with Obalon
Confidential
Advised Amore Pacific
on the foregoing transaction
Convertible Note Financing and Licensing of Rights to Travelan to Paladin
Up to $117 million
Advised Immuron
on the foregoing transaction
Equity Financing
$12.5 million
Advised IBI
on the foregoing transaction
Series C Financing and Strategic Collaboration
$20 million
Advised Vascular Therapies
on the foregoing transaction

Track Record - RM Global

Broker-dealer services are provided through Beech Hill Securities, Inc., a FINRA/SIPC member.